Medizinische Universit├Ąt Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid

Edelsbrunner, ME; Nakano, M; Holzer, P.
Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine.
BMC Gastroenterol. 2009; 9(194): 40-40. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Authors Med Uni Graz:
Edelsbrunner Martin Erich
Holzer Peter

Dimensions Citations:

Plum Analytics:
Number of Figures: 4
| | | |
BACKGROUND: Lafutidine is a histamine H2 receptor antagonist, the gastroprotective effect of which is related to its antisecretory activity and its ability to activate a sensory neuron-dependent mechanism of defence. The present study investigated whether intragastric administration of lafutidine (10 and 30 mg/kg) modifies vagal afferent signalling, mucosal injury, intragastric acidity and gastric emptying after gastric acid challenge. METHODS: Adult rats were treated with vehicle, lafutidine (10 - 30 mg/kg) or cimetidine (10 mg/kg), and 30 min later their stomachs were exposed to exogenous HCl (0.25 M). During the period of 2 h post-HCl, intragastric pH, gastric volume, gastric acidity and extent of macroscopic gastric mucosal injury were determined and the activation of neurons in the brainstem was visualized by c-Fos immunocytochemistry. RESULTS: Gastric acid challenge enhanced the expression of c-Fos in the nucleus tractus solitarii but caused only minimal damage to the gastric mucosa. Lafutidine reduced the HCl-evoked expression of c-Fos in the NTS and elevated the intragastric pH following intragastric administration of excess HCl. Further analysis showed that the gastroprotective effect of lafutidine against excess acid was delayed and went in parallel with facilitation of gastric emptying, measured indirectly via gastric volume changes, and a reduction of gastric acidity. The H2 receptor antagonist cimetidine had similar but weaker effects. CONCLUSION: These observations indicate that lafutidine inhibits the vagal afferent signalling of a gastric acid insult, which may reflect an inhibitory action on acid-induced gastric pain. The ability of lafutidine to decrease intragastric acidity following exposure to excess HCl cannot be explained by its antisecretory activity but appears to reflect dilution and/or emptying of the acid load into the duodenum. This profile of actions emphasizes the notion that H2 receptor antagonists can protect the gastric mucosa from acid injury independently of their ability to suppress gastric acid secretion.
Find related publications in this database (using NLM MeSH Indexing)
Acetamides - pharmacology
Animals -
Cimetidine - pharmacology
Female -
Gastric Acid - metabolism
Gastric Emptying - drug effects Gastric Emptying - physiology
Gastric Mucosa - drug effects
Histamine H2 Antagonists - pharmacology
Hydrochloric Acid - adverse effects Hydrochloric Acid - pharmacology
Hydrogen-Ion Concentration -
Models, Animal -
Neurons, Afferent - drug effects Neurons, Afferent - physiology
Piperidines - pharmacology
Proto-Oncogene Proteins c-fos - metabolism
Pyridines - pharmacology
Rats -
Rats, Sprague-Dawley -
Signal Transduction - drug effects Signal Transduction - physiology
Solitary Nucleus - metabolism
Stomach - drug effects Stomach - innervation Stomach - metabolism
Time Factors -

© Meduni GrazImprint